National Lung Screening Trial
Multi-window CT based Radiomic signatures in differentiating indolent versus aggressive lung cancers in the National Lung Screening Trial: a retrospective study
11
Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era
15
Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening
10
LDCT lung cancer screening in populations at different risk for lung cancer
6
Participation in lung cancer screening programs: are there gender and social differences? A systematic review
12
Lung Cancer Screening
7
The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial
8
The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer.
6
The effect of optimised patient information materials on recruitment in a lung cancer screening trial : an embedded randomised recruitment trial
8
<p>Landscape on CT screening for lung cancer in Asia</p>
18
An integrated digital/clinical approach to smoking cessation in lung cancer screening: study protocol for a randomized controlled trial
14
Screening for type 2 diabetes : literature review and economic modelling
146
Screening for Blood Pressure, Cholesterol and Glucose During National Heart Weeks 1992 1994
10
National screening for barley grain defects
5
Proposals for lung cancer screening in the UK
5
Screening for hyperglycaemia in pregnancy : a rapid update for the National Screening Committee
202
Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial
27
Efficacy and safety of amrubicin hydrochloride for treatment of relapsed small cell lung cancer
5
Several clinical interests regarding lung volume reduction surgery for severe emphysema: meta-analysis and systematic review of randomized controlled trials
8
Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
9